1. Introduction {#s0005}
===============

Alveolar echinococcosis (AE) is a rare zoonosis caused by the larval stage of the fox tapeworm (*Echinococcus multilocularis*) ([@bb0045]; [@bb0080]; [@bb0065]; [@bb0095]). Frequently showing disseminated growth, AE resembles a malignant tumour in its appearance and destructive behaviour. In humans, AE may cause serious, potentially fatal illness ([@bb0045]; [@bb0080]; [@bb0095]; [@bb0040]). It occurs predominantly in temperate-to-cold climate zones of the northern hemisphere, particularly across Central Europe, a large part of North and Central Asia, and some parts of North America ([@bb0045]; [@bb0080]; [@bb0070]). Europe is the historical endemic region for AE, but since the 1980s, almost 90% of cases have occurred in western China ([@bb0110]).

Human infection with *Echinococcus multilocularis* is caused by ingestion of parasite eggs. High-risk groups for AE include dog and cat owners, who may become infected through close contact with their animals ([@bb0075]), and owning a dog is currently a major risk factor for contracting AE ([@bb0035]). In endemic areas, farmers, forestry workers, and hunters have a higher risk of infection than do other occupational groups ([@bb0075]; [@bb0035]). The current epidemiological picture for AE shows that the important main endemic areas for the disease are in Southern Germany, Northern Switzerland, Western Austria and Eastern France in Europe as well as in Western China ([@bb0010]).

AE diagnosis remains a major clinical challenge. The case definition according to Brunetti et al. provides important recognised diagnostic criteria ([@bb0025]). Among available imaging techniques, the most investigated methods are ultrasonography, magnetic resonance imaging (MRI), and computed tomography (CT). Recognised AE classifications are available for ultrasonography and MRI ([@bb0090]; [@bb0085]). The *Echinococcus multilocularis* Ulm classification for CT (EMUC-CT), newly developed by [@bb0050], offers the first description of different morphological types and patterns of AE liver lesions on CT ([@bb0050]). Because of differences in health systems worldwide -- especially between Europe and China -- published studies have reported quite large regional differences, especially in AE lesion sizes. AE is often discovered by chance and very late because of the long incubation period. Therefore, imaging techniques can currently describe only point prevalence or morphological manifestations. It is possible that AE is diagnosed at earlier stages in Europe and later stages in China, but no studies have compared the two patient populations.

AE is rare, so multi-centre studies are required to accumulate sufficient data ([@bb0105]). To advance AE research, universities in European countries and China established a research network in 2016, the Xining--Urumqi--Ulm--Besançon (XUUB) project. The universities of Urumqi and Xining in western China and the universities of Ulm in Germany and Besançon in France have been leading centres in the research and treatment of AE for many years (see map, [Fig. 1](#f0005){ref-type="fig"}). These four institutions are each located in high-endemic areas for AE in their respective countries ([@bb0010]).Fig. 1Centre locations. The map shows the four centres in China and Europe: Xining in central China and Urumqi in the northwest of the country; Besançon in eastern France and Ulm lying at the southeastern border of the Swabian Alps on the border with Bavaria (especially created for this publication).Fig. 1

The aim of the research network was to complete the first investigation and comparison of large AE patient datasets between Europe and China. For this purpose, we compared the number, size, and CT appearance of hepatic AE lesions between patient groups in these regions.

2. Materials and methods {#s0010}
========================

2.1. Study design and inclusion and exclusion criteria {#s0015}
------------------------------------------------------

Retrospectively, we included the 50 most recent abdominal contrast-enhanced CT examinations (*N* = 200) at each centre, performed because of hepatic AE from 09/21/07 to 03/21/18. The number of cases was estimated after consultation with the respective countries involved and the number of CT examinations in recent months. The previous clinical and imaging morphological findings had to have been classified as confirmed AE according to Brunetti et al.\'s case definition ([@bb0025]). Antibody status, possible subsequent therapeutic strategies, and socioeconomic factors were not considered in the inclusion criteria.

2.2. Ethics approval and consent to participate {#s0020}
-----------------------------------------------

For German patients, the study was approved by the Institutional Review Board (IRB) of the Ulm University Hospital and conducted in accordance with the Declaration of Helsinki (ref. No. 409/15). Because of its retrospective design and pseudonymised evaluation of imaging, no ethics approval was necessary for France and China by the local Institutional Review Boards of the Universities Xining, Urumqi and Besancon regarding the national regulations. All data were analysed anonymously.

2.3. Examination and classification {#s0025}
-----------------------------------

The *Echinococcus Multilocularis* Ulm Classification for CT (EMUC-CT) provides a scheme for classifying the very different morphological appearances of hepatic alveolar echinococcosis (HAE) lesions. The classification of all HAE cases according to the EMUC-CT was carried out by the first reader from 09/04/18 to 14/04/2018. Only venous-phase CT scans were used to evaluate the lesions. The largest lesion within a liver was used to determine the primary morphological type, and all further evaluations in this study reference these. A local experienced radiologist at each of the four centres became the second reader for their own 50 cases and independently re-classified the local cases ([Fig. 2](#f0010){ref-type="fig"}). Criteria concerning the classification of the lesions, as well as further technical and disease-related information, were collected on a detailed report form. In addition to the essential patient data (sex and age), technical information included the basic technical modality of the CT scan. The following CT scanners were used in the different centres: Philips ICT, United UCT (Xining); CT-Discovery CT 750 HD, GE Healthcare (Urumqi); Biograph mCT-S (40), Siemens Healthcare (Ulm) and Biograph; Siemens; CTI; Knoxville, TN (Besançon).Fig. 2Study design and course.Fig. 2

The EMUC-CT classification distinguishes five primary morphological lesions: type I, diffuse infiltrating; type II, primarily circumscribed tumour-like; type III, primarily cystoid (two subtypes: type IIIa, intermediate; type IIIb, widespread); and type IV, small cystoid/metastatic; type V, mainly calcified. Subcriteria are given for types I--III. The classification also distinguishes six patterns of calcification: without calcifications, with a central calcification, or with feathery, focal, diffuse, or primarily edge calcifications ([Fig. 3](#f0015){ref-type="fig"}) ([@bb0050]).Fig. 3Overview of the EMUC-CT classification. Left: Primary morphological types I--V and their subcriteria (applicable to types I, II, and III). Right: Patterns of calcification (EMUC-CT = *Echinococcus multilocularis* Ulm Classification for Computed Tomography). The two pillars of the classification are generally considered separately and can then in principle be freely combined. There are two exceptions: The pattern of calcification "with a central calcification\*" can occur only with primary morphology type IV\*, and primary morphology type V is not further characterised by a pattern of calcification.Fig. 3

Disease-related information included the affected liver segments, number of lesions, overall dimensions of the lesions, and measurements of specific areas within them. The largest liver lesion was used to determine the primary morphological type and evaluated as the main lesion of the disease. Where appropriate, other primary morphological types present in smaller lesions were designated as 'second patterns'.

2.4. Statistical analysis {#s0030}
-------------------------

Statistical analysis was performed using SAS Version 9.4 (SAS Institute Inc., Cary, NC, USA). First, a descriptive analysis of the data was performed with respect to the absolute and relative frequencies, as well as measures of central tendency and dispersion. The Shapiro-Wilk test was used to determine whether data were normally distributed. Pearson\'s chi-squared and the exact Fisher test were used to evaluate differences in frequency between two variables. Differences in metric variables from the four centres were evaluated by post-hoc Tukey and Kruskal--Wallis tests based on an analysis of variance results. The level of significance was set at α = 0.05, and *p* \< 0.05 was considered significant with a 5% probability of error. All tests were performed on both sides.

3. Results {#s0035}
==========

3.1. Sex proportion {#s0040}
-------------------

The patient group (*n* = 200) across Xining (*n* = 50), Urumqi (n = 50), Ulm (n = 50), and Besançon (n = 50) had a predominance of women at 110/200 (55%) ([Table 1](#t0005){ref-type="table"}).Table 1Patient characteristics.Table 1XUUB overall\
(N = 200)Xining\
(n = 50)Urumqi\
(n = 50)Ulm\
(n = 50)Besançon\
(n = 50)Sex, n (%) Male90 (45.0)22 (44.0)23 (46.0)21 (42.0)24 (48.0) Female110 (55.0)28 (56.0)27 (54.0)29 (58.0)26 (52.0)Age, n (%) \<18 years8 (4.0)6 (12.0)2 (4.0)0 (0.0)0 (0.0) 18--40 years59 (29.5)20 (40.0)26 (52.0)8 (16.0)5 (10.0) 41--60 years66 (33.0)24 (48.0)18 (36.0)12 (24.0)12 (24.0) 61--80 years50 (25.0)0 (0.0)4 (8.0)26 (52.0)20 (40.0) \>81 years17 (8.5)0 (0.0)0 (0.0)4 (8.0)13 (26.0)  Mean ± SD\
(min--max)Lesion size (mm)95.6 ± 51.8\
(11--261)108.0 ± 53.0\
(21--261)132.7 ± 46.0\
(36--253)71.4 ± 46.39\
(11−202)70.4 ± 32.3\
(13--173)Number of lesions3.2 ± 4.5\
(1--29)3.3 ± 5.3\
(1--27)1.8 ± 1.2\
(1--6)5.0 ± 6.5\
(1--29)2.7 ± 2.4\
(1−12)Age (years)50.1 ± 20.5\
(11--91)35.5 ± 12.6\
(11--55)38.0 ± 13.9\
(16--77)61.3 ± 16.8\
(18--85)65.7 ± 18.3\
(18--91)

3.2. Age distribution {#s0045}
---------------------

The European and Chinese patient populations differed significantly in age (63.5 ± 17.7 vs. 36.8 ± 13.2; p\<0.0001) ([Table 1](#t0005){ref-type="table"}). The mean age of the patients in the two European centres (65.7 ± 18.3 years for Besançon and 61.3 ± 16.8 years for Ulm; overall mean, 63.5 years) was higher than in the two Chinese centres (38.0 ± 13.9 years for Urumqi and 35.5 ± 12.6 years for Xining; overall mean, 36.8 years; *χ2 = 87,98; p* \< 0.0001).

3.3. Size of the largest space-occupying lesion {#s0050}
-----------------------------------------------

Lesion size also differed significantly between the European and Chinese patient populations (70.9 ± 39.8 vs. 120.4 ± 50.8; p\<0.0001). The mean size of the largest space-occupying lesion in all centres was 95.6 ± 51.8 mm. Lesions were smaller in Europe, with a mean measurement of 70.4 ± 32.3 mm for Besançon and 71.4 ± 46.4 mm for Ulm compared to 108.0 ± 53.0 mm for Xining and 132.7 ± 46.0 mm for Urumqi (χ2 = 54,45; p \< 0.0001; [Table 1](#t0005){ref-type="table"}).

3.4. Distribution of CT morphological patterns {#s0055}
----------------------------------------------

The number of lesions differed significantly between the European and Chinese centres (2.6 ± 3.9 in Europe versus 3.8 ± 5.0 in China; *p* = 0.0062), but in a mixed pattern of high and low numbers in each region. The minimum was 1.8 ± 1.2 at Urumqi and the maximum was 5.0 ± 6.5 at Ulm ([Table 1](#t0005){ref-type="table"}). Taking the cases from all centres, the frequencies of the primary morphological lesions decreased from type I to type V. However, the distribution of the primary morphology of the largest lesion was not the same in the European and Chinese centres ([Table 2](#t0010){ref-type="table"}).Table 2Primary morphological types classified according to the EMUC-CT.Table 2N (%)XUUB overall\
(N = 200)Xining\
(n = 50)Urumqi\
(n = 50)Ulm\
(n = 50)Besançon\
(n = 50)Type I85 (42.5)18 (36.0)17 (34.0)22 (44.0)28 (56.0) With cystoid portion55 (64.7)13 (72.2)13 (76.5)11 (50.0)18 (64.3) Without cystoid portion30 (35.3)5 (27.8)4 (23.5)11 (50.0)10 (35.7)Type II67 (33.5)17 (34.0)26 (52.0)12 (24.0)12 (24.0) With cystoid portion55 (82.1)13 (76.5)22 (84.6)10 (83.3)10 (83.3) Without cystoid portion12 (17.9)4 (23.5)4 (15.4)2 (16.7)2 (16.7)Type III27 (13.5)13 (26.0)7 (14.0)4 (8.0)3 (6.0) With more solid portions at the edge23 (85.2)11 (84.6)6 (85.7)4 (100.0)2 (66.7) Without more solid portions at the edge4 (14.8)2 (15.4)1 (14.3)0 (0.0)1 (33.3)Type IIIa8 (4.0)2 (4.0)1 (2.0)2 (4.0)3 (6.0) With more solid portions at the edge7 (87.5)0 (0.0)0 (0.0)0 (0.0)2 (66.7) Without more solid portions at the edge1 (12.5)2 (100.0)1 (100.0)2 (100.0)1 (33.3)Type IIIb19 (9.5)11 (22.0)6 (12.0)2 (4.0)0 (0.0) With more solid portions at the edge16 (84.2)9 (81.8)5 (83.3)0 (0.0)0 (0.0) Without more solid portions at the edge3 (15.8)2 (18.2)1 (16.7)2 (100.0)0 (0.0)Type IV17 (8.5)2 (4.0)0 (0.0)9 (18.0)6 (12.0%)Type V4 (2.0)0 (0.0)0 (0.0)3 (6.0)1 (2.0%)

Type I was by far the most common type in the European centres, accounting for 50% of the primary lesions (28 \[56.0%\] for Besançon and 22 \[44.0%\] for Ulm) versus 35% of primary lesions in China. Type II was the second most common in Europe, with 12 (24.0%) in both centres. In Xining, type I and II frequencies were similar (18 \[36.0%\] and 17 \[34.0%\] cases, respectively). In contrast, type II dominated in Urumqi (26 \[52.0%\] cases compared to 17 \[34.0%\] type I cases). Taking the two localities together, type II was the most prevalent in the Chinese centres overall, accounting for 43% of cases, compared to 24% in Europe.

Type III (IIIa and IIIb combined) was identified much more often in China (20% vs. 7% in Europe), occurring in 13 (26.0%) cases in Xining and 7 (14.0%) in Urumqi, compared to 4 (8.0%) in Ulm and 3 (6.0%) in Besançon. Type IV accounted for 15 (15%) of the largest lesions in Europe and only 2 (2%) in China, where it was identified in only 2 (4.0%) cases in Xining and none in Urumqi. In contrast, it was found in 6 (12.0%) of the largest lesions in Besançon and 9 (18.0%) in Ulm. Type V was not identified in China and was found in only very small numbers in Europe (3 \[6.0%\] in Ulm and 1 \[2.0%\] in Besançon), accounting for 4% of the European patient group.

Thus, patients at the European and Chinese centres differed significantly in the distribution of type II (Europe, *n* = 24 \[24.0%\] vs. China, *n* = 43 \[43.0%\]; *χ2 = 8,10; p* = 0.0044) and type III patterns (Europe, *n* = 7 \[7.0%\] vs. China, *n* = 20 \[20.0%\]; *χ2 = 7,24; p* = 0.0071).

We also find significant difference in the distribution of type I (Europe, *n* = 50 \[50.0%\] vs. China, *n* = 35 \[35.0%\]; *χ2 = 4,60; p* = 0.0319) and type IV (Europe, *n* = 15 \[15.0%\] vs. China, n = 2 \[2.0%\]; Fisher\'s exact test: *p* = 0.0015). We found no significant differences in the distribution of type V (Europe, n = 4 \[4.0%\] vs. China, *n* = 0 \[0.0%\]; Fisher\'s exact test: *p* = 0.1212).

3.5. Lesion size according to CT morphological types {#s0060}
----------------------------------------------------

Mean lesion size and variance differed between CT morphological types and centres ([Fig. 4](#f0020){ref-type="fig"}). Type III lesions were particularly large, and type IV lesions showed the smallest mean lesion size and variance. They also were significantly smaller than all of the other lesions (*p* \< 0.05).Fig. 4Measures of central tendency and dispersion of the lesion size in the different centres. Box-plots showing measures of central tendency and dispersion of the lesion size, according to the EMUC-CT primary morphological types and centres. A: Xining, China; B: Urumqi, China; C: Ulm, Germany; D: Besançon, France.Fig. 4

3.6. Second pattern {#s0065}
-------------------

The analysis also showed a second pattern of primary morphology in smaller lesions in 78/200 (39.0%) cases, with a different primary morphology from that of the main lesion. [Table 3](#t0015){ref-type="table"} gives the distribution of these lesions, designated as 'second patterns', at the different centres. Type IV was by far the most common second pattern, accounting for 56 (71.79%) cases, followed by 15 (19.23%) cases of the more rare type V. The distribution was similar across study centres.Table 3Morphological types found in additional lesions ('second patterns') stratified according to centre.Table 3N (%)XUUB overall\
(N = 200)Xining\
(n = 50)Urumqi\
(n = 50)Ulm\
(n = 50)Besançon\
(n = 50)Type I2 (2.6)1 (5.9)0 (0.0)0 (0.0)1 (4.4)Type II3 (3.9)0 (0.0)0 (0.0)3 (16.7)0 (0.0)Type III2 (2.6)1 (5.9)0 (0.0)1 (5.6)0 (0.0)Type IV56 (71.8)11 (64.7)17 (85.0)11 (61.1)17 (73.9)Type V15 (19.2)4 (23.5)3 (15.0)3 (16.7)5 (21.7)Overall78 (39.0)17 (34.0)20 (40.0)18 (36.0)23 (46.0)

3.7. Calcification pattern {#s0070}
--------------------------

The six calcification patterns, which constitute the second pillar of the EMUC-CT scheme, showed a similar distribution in the largest lesions at all four centres. The 'without calcifications' pattern, however, was identified more often in European centres, with a trend towards 'feathery calcifications' and 'diffuse calcifications' in the two Chinese centres. Only a few cases had a 'central calcification', and all were exclusively in type IV lesions (from Xining, Ulm, and Besançon; [Table 4](#t0020){ref-type="table"}).Table 4Calcification pattern according to XUUB centre.Table 4N (%)XUUB overall\
(N = 200)Xining\
(n = 50)Urumqi\
(n = 50)Ulm\
(n = 50)Besançon\
(n = 50)Without calcifications22 (11.0)2 (4.0)1 (2.0)12 (24.0)7 (14.0)With feathery calcifications41 (20.5)12 (24.0)15 (30.0)4 (8.0)10 (20.0)With diffuse calcifications74 (37.0)23 (46.0)18 (36.0)19 (38.0)14 (28.0)With focal calcifications41 (20.5)9 (18.0)13 (26.0)9 (18.0)10 (20.0)With calcifications primarily at the edge13 (6.5)3 (6.0)3 (6.0)2 (4.0)5 (10.0)With a central calcification5 (2.5)1 (2.0)0 (0.0)1 (2.0)3 (6.0)No classification of type V4 (2.0)0 (0.0)0 (0.0)3 (6.0)1 (2.0)

4. Discussion {#s0075}
=============

General information: In this study, we compared retrospectively collected CT data for a large group (*N* = 200) of patients with AE between the major endemic countries in Europe (Besançon, France; Ulm, Germany) and Asia (Xining and Urumqi, China). The results show significant differences between patients in Europe and China for lesion size and number and for patient age. The frequency and distribution of CT morphological patterns also differed by centre and region.

Age distribution: The large discrepancy in mean patient age between Chinese and European centres is particularly striking because the Chinese patients were younger. Several studies have already reported that echinococcosis occurs more often in children in western China than in other endemic regions of the world ([@bb0115]; [@bb0055]; [@bb0030]). The high prevalence of endemic disease in young people indicates that infection occurs at an early age in the rural areas of north-western and western-central China, where stray dogs and herding dogs are thought to be responsible for dissemination of *Echinococcus multilocularis* eggs ([@bb0125]).

Sex distribution: The study also shows that in the four study centres, AE patients were more often female. This result is in keeping with previous reports of a predominance of women in this patient population ([@bb0115]).

Size of the largest space-occupying lesion: Lesion sizes differed significantly between the European and Chinese groups and were significantly larger in patients from the Chinese centres. In Europe, AE is often an incidental finding in asymptomatic older patients during a routine health check. Studies from China confirm that quite large lesions are frequently detected in the Asian region because of late diagnosis ([@bb0100]). Patients in China commonly do not present for medical diagnosis and treatment until they are symptomatic, usually at a late stage, because of residence in remote rural areas ([@bb0015]; [@bb0120]). The pattern of more advanced lesions in younger patients in China and less advanced lesions in older patients in Europe may seem paradoxical. Possible explanations include the more frequent contact that children in China may have with infected dogs because of a pastoral lifestyle, higher environmental infection pressure, and heavier egg burden at the time of infection. However, more rapid disease progression in a relatively immature immune system in early life cannot be ruled out.

Distribution of CT morphological patterns: The distribution of CT morphological types in the largest lesion differed between the European and Chinese groups. The primary morphology of the main lesion was most commonly type I and least commonly type V across all centres. These results correspond to the frequency distribution found in the German population when establishing the EMUC-CT in 2016 ([@bb0050]). However, the centres in Europe and China differed in their individual distribution of the different types of primary morphology: European centres had a clear predominance of type I over type II whereas the occurrence of these types was equal in Xining and type II showed predominance over type I in Urumqi. Type III, with strikingly large lesions, was more common at the two Chinese centres than in Europe. However, we also found significant differences in prevalence between Type II and Type III patterns in the European and Chinese patient groups. Type IV was seldom the main lesion, yet it was found with some regularity and almost exclusively in both European centres. Furthermore, it was by far the most common second pattern in patient populations from both regions. Type V was identified as the main lesion only among patients from the European centres and in very small numbers. So far, published descriptions of distributions of different CT morphological AE types are scant. It is possible that different stages explain the different types.

Calcification pattern: The distribution of the six calcification patterns that form the second pillar of the EMUC-CT was relatively similar at all centres. The pattern 'without calcifications' was detectably more common in the European centres, and the patterns 'feathery calcifications' and 'diffuse calcifications' tended to be more frequent in the two Chinese centres. For AE at least, calcification is reported to become more obvious as the disease progresses ([@bb0060]). CT alone does not provide the entire information about the viability of the lesions, even in the case of highly calcified lesions. However, the strength of calcification is particularly important as a progression parameter because increasing calcification can be a sign of increasing lesion regression or of rapid, strong inflammatory reaction. Current studies on the strength of calcifications show, viewed the other way around, that especially low calcified lesions are associated with highest PET activity ([@bb0020]). Each imaging modality offers its specific advantages also for estimating the activity of AE lesions. For example, in MRI this would be the presence of the small alveoli ([@bb0005]). MRI, however, in contrast to CT can only provide insufficient information on the calcification of a lesion.

Given the retrospective and purely descriptive nature of this study, it has several limitations. Among these are different imaging preferences and opportunities between the countries, as there were differences and a wide dispersion of imaging rates in the recruitment period. This factor must be considered as a possible confounder.

Nevertheless, this work provides a first holistic multicentric overview of the CT-based AE liver lesion morphology in Europe and China, using a classification system that allowed for direct comparison. The study design does not allow direct conclusions as to why the proportion of CT types, lesion size, and mean patient age differed between China and Europe. Further research should address these and other questions.

5. Conclusions {#s0080}
==============

This study comparing patients with AE in Europe and China raises many questions and leaves open many possibilities for interpretation. Different lesion sizes with more extended liver infestations in China, as well as difference in mean ages and the differential distribution of CT morphological types between regions, raises the question of whether patients in Europe might have been at earlier stages of disease. In particular, there is a question of whether the type IV pattern could be the initial form of a lesion: these lesions were small and presented as a main lesion in the European group while at the same time representing the most common second pattern across centres. It is possible that these type IV lesions evolve into different types, but these questions need to be investigated in further multicentre studies.
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